| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $633K | +97.9% |
| Cost of Revenue | $210K | +30.7% |
| R&D Expense | $1.7M | -0.7% |
| SG&A Expense | $10.7M | +170.3% |
| Operating Income | -$12.0M | -116.2% |
| Interest Expense | $20K | — |
| Income Tax | $0 | — |
| Net Income | -$18.0M | -230.2% |
| EPS (Basic) | -$1.76 | +2.8% |
| EPS (Diluted) | -$1.76 | +2.8% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $447K | -93.1% |
| Accounts Receivable | $34K | — |
| Current Assets | $3.1M | -54.8% |
| Total Assets | $3.7M | -49.8% |
| Current Liabilities | $5.1M | +384.0% |
| Total Liabilities | $5.5M | +337.7% |
| Stockholders' Equity | -$6.2M | +57.5% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$9.8M | -160.0% |
| Capital Expenditures | $29K | -79.9% |
| Investing Cash Flow | -$29K | +79.9% |
| Financing Cash Flow | $5.2M | -49.0% |
| Free Cash Flow | -$9.8M | -151.3% |